Home/Contractors/Rafa Laboratories LTD

Federal Contractor Profile

Rafa Laboratories LTD

Federal contracting record: $156M obligated across 10 awards from 1 agencies, FY 20172025.

$156M
Total Obligated
10
Award Records
1
Agencies Served
2
NAICS Codes

Company Profile

UEI (Unique Entity Identifier)

CKDNTKNDPMJ6

CAGE Code

0905A

Parent Organization

Rafa Laboratories LTD

Address

3 ZEEV LEV, JERUSALEM, 009777019

First Federal Award

Dec 22, 2016

Most Recent Award

Sep 30, 2025

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

  • Department of Health and Human Services

    100.0% of total obligations

    $156M

Top NAICS Activity

  • 325412

    PHARMACEUTICAL PREPARATION MANUFACTURING

    8 awards

    $134M
  • 541714

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

    2 awards

    $21M

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Sep 30, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA$12M
Sep 30, 2025Department of Health and Human ServicesASPR/ORM-SNS325412RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)$21M
Sep 22, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT, INCLUDING U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL, OF ATROPINE AUTOINJECTOR FOR PEDIATRIC USE USING AN IMPROVED VERSION OF RAFA LABORATORIES, LTD.S (RAFAS) FDA-APPROVED SI$1.7M
Sep 19, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT, INCLUDING U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL, OF ATROPINE AUTOINJECTOR FOR PEDIATRIC USE USING AN IMPROVED VERSION OF RAFA LABORATORIES, LTD.S (RAFAS) FDA-APPROVED SI$7.7M
Sep 21, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325412RAFA DO 6$23M
Sep 29, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325412ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE$7.8M
Sep 25, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325412TASK ORDER FOR ADDITIONAL PRODUCTS$9.7M
Aug 8, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325412TASK ORDER FOR ADDITIONAL PRODUCTS$6.2M
Mar 13, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ$32M
Jun 30, 2017Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ$28M
Jan 31, 2017Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - TO1$7.1M
Dec 22, 2016Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ$10K

Related Contractors

Other companies active in NAICS 325412PHARMACEUTICAL PREPARATION MANUFACTURING.

Track Rafa Laboratories LTD Recompetes Before They Post

Mindy monitors Rafa Laboratories LTD's active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts